Chemotherapy in nasopharyngeal carcinoma: review of results at University Hospital, Kuala Lumpur

Med J Malaysia. 1989 Dec;44(4):329-33.

Abstract

Nasopharyngeal carcinoma (NPC) is one of the commonest presentation of head and neck cancers in Malaysia, especially in the Chinese. The standard treatment is radical radiotherapy to the post-nasal space and the neck. Chemotherapy is given to patients with primary advanced disease and to patients with recurrence. The study reviews results of chemotherapy given to 33 patients at the University Hospital, Kuala Lumpur, over the last four years.

MeSH terms

  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Cyclophosphamide / therapeutic use
  • Doxorubicin / therapeutic use
  • Humans
  • Methotrexate / therapeutic use
  • Nasopharyngeal Neoplasms / drug therapy*
  • Nasopharyngeal Neoplasms / secondary
  • Vincristine / therapeutic use

Substances

  • Vincristine
  • Doxorubicin
  • Cyclophosphamide
  • Methotrexate